Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 5, 2013, Pages 1114-1122

  Cross, Sara ^a   Önen, Nur ^a   Gase, Amber ^a   Overton, Edgar Turner ^b   Ances, Beau M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; HIV associated neurocognitive disorders (HAND); International HIV Dementia Scale (IHDS)

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; INCOME; INTERNATIONAL HIV DEMENTIA SCALE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; URBAN AREA;

ADULT; AIDS DEMENTIA COMPLEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS;

EID: 84891360925     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9505-1     Document Type: Article

References (53)

1. An Q, Prejean J, Hall HI (2012) Racial disparity in U.S. diagnoses of acquired immune deficiency syndrome, 2000-2009. Am J Prev Med 43:461-466. doi: 10.1016/j.amepre.2012.07.040
2. Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86-92. doi: 10.1055/s-2006-956759
3. Andel R, Vigen C, Mack WJ, Clark LJ, Gatz M (2006) The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc 12:147-152. doi: 10.1017/S1355617706060206
4. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799. doi: 10.1212/01.WNL.0000287431.88658.8b
5. Basso MR, Bornstein RA (2000) Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol 22:208-218. doi: 10.1076/1380-3395(200004)22:2;1-1
6. Becker JT, Dew MA, Aizenstein HJ, Lopez OL, Morrow L, Saxton J (2011) Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care STDS 25:351-357. doi: 10.1089/apc.2011.0051
7. Centers for Disease Control and Prevention (2004) Indicators for chronic disease surveillance. MMWR 53:19-27
8. Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I, HIV Neurobehavioral Research Center Group (2005) Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64:1343-1347
9. Cysique LA, Deutsch R, Atkinson JH, Young C, Marcotte TD, Dawson L, Grant I, Heaton RK, HNRC Group (2007) Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc 1:1-11. doi: 10.1017/S1355617707070026
10. Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73:342-348. doi: 10.1212/WNL.0b013e3181ab2b3b
11. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I, CHARTER Group (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25:1747-1751. doi: 10.1097/QAD. 0b013e32834a40cd
12. Fabbiani M, Ciccarelli N, Tana M, Farina S, Baldonero E, Di Cristo V, Colafigli M, Tamburrini E, Cauda R, Silveri MC, Grima P, Di Giambenedetto S (2013) Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med 14:136-144. doi: 10.1111/j.1468-1293.2012.01044
13. Ford ES (2013) Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010. J Am Coll Cardiol 61:2249-2252. doi: 10.1016/j.jacc.2013.03.023
14. Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, Soukup VM (2013) Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr 62:487-495. doi: 10.1097/QAI.0b013e31827f1bdb
15. Haddow LJ, Floyd S, Copas A, Gilson RJ (2013) A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS ONE 8:e61826. doi: 10.1371/journal.pone.0061826
16. Hawkins LA, Kilian S, Firek A, Kashner TM, Firek CJ, Silvet H (2012) Cognitive impairment and medication adherence in outpatients with heart failure. Heart Lung 41:572-582. doi: 10.1016/j.hrtlng.2012.06.001
17. Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant I (1994) Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 56:8-17
18. Heaton RK, Clifford DB, Franklin DR, Woods SB, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 75:2087-2096. doi: 10.1212/WNL.0b013e318200d727
19. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature and predictors. J Neurovirol 17:3-16. doi: 10.1007/s13365-010-0006-1
20. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M (2002) Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 59:1944-1950
21. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M (2004) Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 18(Suppl 1):S19-S25. doi: 10.1097/01.aids.0000125980.64033.f
22. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S (1997) A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 16:965-980. doi: 10.1002/(SICI)1097-0258
23. Jorm AF, Jolley D (1998) The incidence of dementia: a meta-analysis. Neurology 51:728-733
24. Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ (2011) Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDs 25:95-101. doi: 10.1089/apc.2010.0292
25. Kalechstein AD, Newton TF, van Gorp WG (2003) Neurocognitive functioning is associated with employment status: a quantitative review. J Clin Exp Neuropsychol 25:1186-1191. doi: 10.1076/jcem.25.8.1186.16723
26. Katz MJ, Lipton RB, Hall CB, Zimmerman ME, Sanders AE, Verghese J, Dickson DW, Derby CA (2012) Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord 26:335-343. doi: 10.1097/WAD.0b013e31823dbcfc
27. Kissel EC, Pukay-Martin ND, Borenstein RA (2005) The relationship between age and cognitive function in HIV-infected men. J Neuropsychiatry Clin Neurosci 17:180-184. doi: 10.1176/appi.neuropsych.17.2.180
28. Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606-613. doi: 10.1046/j.1525-1497.2001.016009606.x, doi: 10.1046%2Fj.1525-1497.2001.016009606. x-blank
29. Lescure FX, Omland LH, Engsig FN, Roed C, Gerstoft J, Pialoux G, Kronborg G, Larsen CS, Obel N (2011) Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. Clin Infect Dis 52:235-243. doi: 10.1093/cid/ciq041
30. Letendre SL, Ellis RJ, Ances BM, McCutchan JA (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18:45-55
31. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, Ances BM, Grant I, CHARTER Group (2012) Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology 78:485-492. doi: 10.1212/WNL.0b013e3182478d64
32. Morgan EE, Wood SP, Smith C, Weber E, Scott JC, Grant I, HIV Neurobehavioral Research Program (HNRP) Group (2012) Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav 16:2279-2285. doi: 10.1007/s10461-012-0229-7
33. Muniyandi K, Venkatesan J, Arutselvi T, Jayaseelan V (2012) Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS. Indian J Psychiatry 54:149-153. doi: 10.4103/0019-5545.99534
34. Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, Booth R, Williams ML, Watters J, Anderson M, Braunstein M (1995) Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav 9:242-250. doi: 10.1037/0893-164X.9.4.242
35. Njamnshi AK, Bissek AC, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, Fonsah JY, Kuate CT, Angwafor SA, Dema F, Njamnshi DM, Kouanfack C, Djientcheu Vde P, Muna WF, Kanmogne GD (2009) Risk factors for HIV-associated neurocognitive disorders (HAND) in Sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci 285:149-153. doi: 10.1016/j.jns.2009.06. 043
36. Overton ET, Kauwe JS, Paul R, Tashima K, Tate DF, Patel P, Carpenter CC, Patty D, Brooks JT, Clifford DB (2011) Performances on the Cog State and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav 15:1902-1909. doi: 10.1007/s10461-011-0033-9
37. Overton ET, Azad TD, Parker N, Demarco Shaw D, Frain J, Spitz T, Westerhaus E, Paul R, Clifford DB, Ances BM (2013) The Alzheimer's Disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol 19:109-116. doi: 10.1007/s13365-012-0147-5
38. Richardson MA, Morgan EE, Vielhauer MJ, Cuevas CA, Buondonno LM, Keane TM (2005) Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample. AIDS Care 17:1013-1021. doi: 10.1080/09540120500100858
39. Robertson KR, Smurzinski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915-1921. doi: 10.1097/QAD.0b013e32828e4e27
40. Robinson-Papp J, Elliott KJ, Simpson DM (2009) HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep 6:146-152. doi: 10.1007/s11904-009-0020-1
41. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia scale: a new rapid screening test for HIV dementia. AIDS 19:1367-1374
42. Singh D, Sunpath H, John S, Eastham L, Gouden R (2008) The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts - a preliminary report. Afr J Psychiatry 11:282-286
43. Stern R, Silva S, Chaisson N, Evans D (1996) Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol 53:148-153. doi: 10.1001/archneur.1996. 00550020052015
44. Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder KS, Dana Consortium on the Therapy of HIV- Dementia and Related Cognitive Disorders (2001) Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol 58:473-479. doi: 10.1001/archneur.58.3.473
45. The Mind Exchange Working Group (2013) Assessment, diagnosis and treatment of HIV-associated neurocognitive disorder: a consensus report of the Mind Exchange Program. Clin Infect Dis 56:1004-1017. doi: 10.1093/cid/cis975
46. Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW (2003) Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retrovir 19:643-652. doi: 10.1089/088922203322280856
47. United States Department of Agriculture and United States Department of Health and Human Services (2005) Dietary guidelines for Americans. Chapter 9. Alcoholic Beverages. US Government Printing Office, Washington DC, pp 43-46
48. Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G (2011) Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 77:1729-1736. doi: 10.1212/WNL.0b013e318236ef23
49. Valcour VG (2011) Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools. Top Antivir Med 19:175-180
50. Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63:822-827
51. Valcour V, Paul R, Neuhaus J, Shikuma C (2011) The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 17:190-195. doi: 10.1017/S1355617710001438
52. van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG (1999) The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc 5:534-539
53. Zipursky AR, Gogolishvilli D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB (2013) Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS 27:2385-2401. doi: 10.1097/QAD.0b013e328363bf56